A detailed history of Global Alpha Capital Management Ltd. transactions in Haemonetics Corp stock. As of the latest transaction made, Global Alpha Capital Management Ltd. holds 17,101 shares of HAE stock, worth $1.09 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
17,101
Previous 10,025 70.58%
Holding current value
$1.09 Million
Previous $805,000 65.84%
% of portfolio
0.1%
Previous 0.05%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 07, 2025

BUY
$71.16 - $93.38 $503,528 - $660,756
7,076 Added 70.58%
17,101 $1.34 Million
Q3 2024

Nov 08, 2024

BUY
$72.45 - $91.58 $726,311 - $918,089
10,025 New
10,025 $805,000

Others Institutions Holding HAE

About HAEMONETICS CORP


  • Ticker HAE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 51,316,500
  • Market Cap $3.28B
  • Description
  • Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...
More about HAE
Track This Portfolio

Track Global Alpha Capital Management Ltd. Portfolio

Follow Global Alpha Capital Management Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Global Alpha Capital Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Global Alpha Capital Management Ltd. with notifications on news.